Log in
JSE:APN

148364 Stock Forecast, Price & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2.87 million shs
Average Volume1.87 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business includes operating subsidiaries in Europe, Commonwealth of Independent States (CIS), Latin America, the Middle East and North Africa, Canada, as well as Mauritius-based Aspen Global Incorporated. The South African business provides branded, generic, over-the-counter, consumer health and infant nutritional products, which are supplied to pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders and retail stores across the private and public sectors in South Africa. Its business in Asia Pacific includes operations in Australasia, the Philippines, Taiwan and Japan.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+27-11-2396100
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive APN News and Ratings via Email

Sign-up to receive the latest news and ratings for APN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











148364 (JSE:APN) Frequently Asked Questions

What other stocks do shareholders of 148364 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 148364 investors own include Steinhoff International Holdings N.V. (SNH.F) (SNH), Wirecard AG (WDI.F) (WDI), Provident Financial (PFG), MC Mining Limited (MCM.L) (MCM), The Boeing (BA), AstraZeneca PLC (AZN.L) (AZN) and Altaba (AABA).

Who are 148364's key executives?

148364's management team includes the following people:
  • Stephen Bradley Saad, Group Chief Executive, Executive Director (Age 53)
  • Michael Guy Attridge, Deputy Group Chief Executive, Executive Director (Age 56)
  • Riaan Verster, Company Secretary & Group Governance Officer (Age 41)
  • Kuseni Douglas Dlamini, Non-Executive Chairman of the Board (Age 49)
  • Roy Cecil Andersen CPA, Lead Independent Non-Executive Director (Age 69)
  • Christopher Nattle Mortimer, Non-Executive Director (Age 56)
  • David Redfern, Non-Executive Director (Age 51)
  • John Frederick Buchanan, Non-Executive Independent Director (Age 72)

What is 148364's stock symbol?

148364 trades on the JSE under the ticker symbol "APN."

How do I buy shares of 148364?

Shares of APN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is 148364's official website?

The official website for 148364 is www.aspenpharma.com.

How can I contact 148364?

148364's mailing address is Woodmead, JOHANNESBURG, 2194, South Africa. The company can be reached via phone at +27-11-2396100.

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.